• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

循环肿瘤细胞作为胰腺导管腺癌的生物标志物

Circulating Tumor Cells as a Biomarker in Pancreatic Ductal Adenocarcinoma.

作者信息

Liu Han, Sun Bo, Wang Shengnan, Liu Congjin, Lu Yun, Li Ding, Liu Xingdang

机构信息

Department of Nuclear Medicine, Huashan Hospital, Fudan University, Shanghai, China.

Department of General Surgery, Huashan Hospital, Fudan University, Shanghai, China.

出版信息

Cell Physiol Biochem. 2017;42(1):373-382. doi: 10.1159/000477481. Epub 2017 May 25.

DOI:10.1159/000477481
PMID:28558380
Abstract

BACKGROUND/AIMS: Circulating tumor cells (CTCs) are valuable in both basic research and clinical application for cancer management. In the current study, we evaluated the diagnostic value of CTCs in pancreatic ductal adenocarcinoma (PDAC).

METHODS

In total, 143 blood samples from 95 consecutively diagnosed PDAC patients and 48 healthy donors were collected. Combined data from immunostaining of CD45, DAPI and fluorescence in situ hybridization (FISH) with chromosome 8 centromere (CEP8) probe were used to identify CTCs. Cells with features of CD45-/DAPI+/CEP8>2 were detected as CTCs.

RESULTS

CTCs were classified as triploid, tetraploid and multiploid based on chromosome 8 copy number. CTC subtype composition was significantly different among groups. Both subtype number and total CTC number were significantly increased in PDAC patients, compared to healthy controls. Total CTC number had 75.8% sensitivity and 68.7% specificity at a cutoff value of 2 cells/3.2 mL. This study is the first to report that CTC subtype number is also useful in cancer diagnosis. Sensitivity was 53.7% and specificity was 85.4% at a cutoff point of 2 CTC subtypes. The diagnostic value of both total CTC number and CTC subtype number was a little poorer than CA199.

CONCLUSIONS

Both CTC subtype and total CTC number may serve as potential biomarkers for PDAC.

摘要

背景/目的:循环肿瘤细胞(CTC)在癌症研究的基础研究和临床应用中均具有重要价值。在本研究中,我们评估了CTC在胰腺导管腺癌(PDAC)中的诊断价值。

方法

共收集了95例连续确诊的PDAC患者和48例健康供体的143份血样。结合CD45免疫染色、DAPI和8号染色体着丝粒(CEP8)探针荧光原位杂交(FISH)的数据来鉴定CTC。具有CD45-/DAPI+/CEP8>2特征的细胞被检测为CTC。

结果

根据8号染色体拷贝数,CTC被分为三倍体、四倍体和多倍体。各组间CTC亚型组成存在显著差异。与健康对照相比,PDAC患者的亚型数量和总CTC数量均显著增加。在截断值为2个细胞/3.2 mL时,总CTC数量的敏感性为75.8%,特异性为68.7%。本研究首次报道CTC亚型数量在癌症诊断中也具有作用。在截断点为2个CTC亚型时,敏感性为53.7%,特异性为85.4%。总CTC数量和CTC亚型数量的诊断价值均略低于CA199。

结论

CTC亚型和总CTC数量均可作为PDAC的潜在生物标志物。

相似文献

1
Circulating Tumor Cells as a Biomarker in Pancreatic Ductal Adenocarcinoma.循环肿瘤细胞作为胰腺导管腺癌的生物标志物
Cell Physiol Biochem. 2017;42(1):373-382. doi: 10.1159/000477481. Epub 2017 May 25.
2
Clinical significance of pancreatic circulating tumor cells using combined negative enrichment and immunostaining-fluorescence in situ hybridization.联合阴性富集与免疫染色-荧光原位杂交检测胰腺循环肿瘤细胞的临床意义
J Exp Clin Cancer Res. 2016 Apr 12;35:66. doi: 10.1186/s13046-016-0340-0.
3
Patterns of circulating tumor cells identified by CEP8, CK and CD45 in pancreatic cancer.胰腺癌中 CEP8、CK 和 CD45 鉴定的循环肿瘤细胞模式。
Int J Cancer. 2015 Mar 1;136(5):1228-33. doi: 10.1002/ijc.29070. Epub 2014 Jul 21.
4
A combination of circulating tumor cells and CA199 improves the diagnosis of pancreatic cancer.循环肿瘤细胞与 CA199 的联合检测可提高胰腺癌的诊断率。
J Clin Lab Anal. 2022 May;36(5):e24341. doi: 10.1002/jcla.24341. Epub 2022 Mar 25.
5
Prognostic impact of circulating tumor cells in patients with ampullary cancer.循环肿瘤细胞对壶腹癌患者预后的影响。
J Cell Physiol. 2018 Jun;233(6):5014-5022. doi: 10.1002/jcp.26353. Epub 2018 Jan 4.
6
CTC phenotyping for a preoperative assessment of tumor metastasis and overall survival of pancreatic ductal adenocarcinoma patients.CTC 表型分析用于术前评估胰腺导管腺癌患者的肿瘤转移和总生存期。
EBioMedicine. 2019 Aug;46:133-149. doi: 10.1016/j.ebiom.2019.07.044. Epub 2019 Jul 30.
7
[The value of circulating tumor cells detected by chromosome centromere probe identification in diagnosis of non-small cell lung cancer].[染色体着丝粒探针鉴定检测循环肿瘤细胞在非小细胞肺癌诊断中的价值]
Zhonghua Jie He He Hu Xi Za Zhi. 2018 Oct 12;41(10):772-777. doi: 10.3760/cma.j.issn.1001-0939.2018.10.005.
8
Molecular detection of epithelial-mesenchymal transition markers in circulating tumor cells from pancreatic cancer patients: Potential role in clinical practice.循环肿瘤细胞中上皮-间充质转化标志物的分子检测:在临床实践中的潜在作用。
World J Gastroenterol. 2019 Jan 7;25(1):138-150. doi: 10.3748/wjg.v25.i1.138.
9
Circulating tumour cells as a biomarker for diagnosis and staging in pancreatic cancer.循环肿瘤细胞作为胰腺癌诊断和分期的生物标志物
Br J Cancer. 2016 Jun 14;114(12):1367-75. doi: 10.1038/bjc.2016.121.
10
Microfluidic Isolation of Circulating Tumor Cells and Cancer Stem-Like Cells from Patients with Pancreatic Ductal Adenocarcinoma.微流控技术从胰腺导管腺癌患者中分离循环肿瘤细胞和癌症干细胞样细胞。
Theranostics. 2019 Feb 20;9(5):1417-1425. doi: 10.7150/thno.28745. eCollection 2019.

引用本文的文献

1
Blood-based biomarkers in pancreatic ductal adenocarcinoma: developments over the last decade and what holds for the future- a review.胰腺导管腺癌的血液生物标志物:过去十年的进展及未来展望——综述
Front Oncol. 2025 Apr 22;15:1555963. doi: 10.3389/fonc.2025.1555963. eCollection 2025.
2
Stem cell-like circulating tumor cells identified by Pep@MNP and their clinical significance in pancreatic cancer metastasis.通过Pep@MNP鉴定的干细胞样循环肿瘤细胞及其在胰腺癌转移中的临床意义。
Front Oncol. 2024 Jun 25;14:1327280. doi: 10.3389/fonc.2024.1327280. eCollection 2024.
3
Circulating tumor cells as potential prognostic biomarkers for early-stage pancreatic cancer: A systematic review and meta-analysis.
循环肿瘤细胞作为早期胰腺癌潜在的预后生物标志物:一项系统综述和荟萃分析。
World J Clin Oncol. 2023 Nov 24;14(11):504-517. doi: 10.5306/wjco.v14.i11.504.
4
Progress on diagnostic and prognostic markers of pancreatic cancer.胰腺癌诊断和预后标志物的研究进展。
Oncol Res. 2023 Apr 10;31(2):83-99. doi: 10.32604/or.2023.028905. eCollection 2023.
5
ALCAM: A Novel Surface Marker on EpCAM Circulating Tumor Cells.活化白细胞黏附分子:上皮细胞黏附分子循环肿瘤细胞上的一种新型表面标志物。
Biomedicines. 2022 Aug 16;10(8):1983. doi: 10.3390/biomedicines10081983.
6
Integrated Workflow for the Label-Free Isolation and Genomic Analysis of Single Circulating Tumor Cells in Pancreatic Cancer.用于胰腺癌中无标记循环肿瘤细胞的分离和基因组分析的集成工作流程。
Int J Mol Sci. 2022 Jul 16;23(14):7852. doi: 10.3390/ijms23147852.
7
A combination of circulating tumor cells and CA199 improves the diagnosis of pancreatic cancer.循环肿瘤细胞与 CA199 的联合检测可提高胰腺癌的诊断率。
J Clin Lab Anal. 2022 May;36(5):e24341. doi: 10.1002/jcla.24341. Epub 2022 Mar 25.
8
Advances in the Detection of Pancreatic Cancer Through Liquid Biopsy.通过液体活检检测胰腺癌的进展
Front Oncol. 2021 Dec 21;11:801173. doi: 10.3389/fonc.2021.801173. eCollection 2021.
9
Clinical prognostic value of circulating tumor cells in the treatment of pancreatic cancer with gemcitabine chemotherapy.循环肿瘤细胞在吉西他滨化疗治疗胰腺癌中的临床预后价值。
Exp Ther Med. 2021 Oct;22(4):1140. doi: 10.3892/etm.2021.10574. Epub 2021 Aug 8.
10
Biomarkers in the diagnosis of pancreatic cancer: Are we closer to finding the golden ticket?在胰腺癌诊断中的生物标志物:我们是否更接近找到“金标准”?
World J Gastroenterol. 2021 Jul 14;27(26):4045-4087. doi: 10.3748/wjg.v27.i26.4045.